The double strand breaks are created either by site - specific designer zinc finger endonucleases or triple helix forming oligonucleotides that are able to recognise and induce repair of specific mutations in the genome.
Its competitors — designer proteins called zincfinger nucleases and TALENs — also precisely alter chosen DNA sequences, and several companies are already exploiting them for therapeutic purposes in clinical trials.